Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Adjuvant trastuzumab in HER2-positive breast cancer.

Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Press M, Mackey J, Glaspy J, Chan A, Pawlicki M, Pinter T, Valero V, Liu MC, Sauter G, von Minckwitz G, Visco F, Bee V, Buyse M, Bendahmane B, Tabah-Fisch I, Lindsay MA, Riva A, Crown J; Breast Cancer International Research Group.

N Engl J Med. 2011 Oct 6;365(14):1273-83. doi: 10.1056/NEJMoa0910383.

2.

Human coagulation factor FVIIa (recombinant) in the management of limb-threatening bleeds unresponsive to alternative therapies: results from the NovoSeven emergency-use programme in patients with severe haemophilia or with acquired inhibitors.

Arkin S, Blei F, Fetten J, Foulke R, Gilchrist GS, Heisel MA, Key N, Kisker CT, Kitchen C, Shafer FE, Shah PC, Strickland D.

Blood Coagul Fibrinolysis. 2000 Apr;11(3):255-9.

PMID:
10870806
3.

In vitro assessment of the effects of granulocyte-macrophage colony-stimulating factor on primary human tumors and derived lines.

Foulke RS, Marshall MH, Trotta PP, Von Hoff DD.

Cancer Res. 1990 Oct 1;50(19):6264-7. Review.

4.

Korean hemorrhagic fever: propagation of the etiologic agent in a cell line of human origin.

French GR, Foulke RS, Brand OA, Eddy GA, Lee HW, Lee PW.

Science. 1981 Mar 6;211(4486):1046-8.

PMID:
6110243
5.

Structural polypeptides of Hazara virus.

Foulke RS, Rosato RR, French GR.

J Gen Virol. 1981 Mar;53(Pt 1):169-72.

PMID:
7276913
6.

Observations on natural and laboratory infection of rodents with the etiologic agent of Korean hemorrhagic fever.

Lee HW, French GR, Lee PW, Baek LJ, Tsuchiya K, Foulke RS.

Am J Trop Med Hyg. 1981 Mar;30(2):477-82.

PMID:
6786119
7.

A health and nutrition study among Michigan Indians.

Willet WC, Foulke RA, Robson JR, Block WD, Perlman LV.

Mich Med. 1970 Apr;69(7):305-11. No abstract available.

PMID:
4393576

Supplemental Content

Loading ...
Support Center